Sensitivity of personalized circulating tumor DNA assay in advanced cutaneous squamous cell carcinoma
- PMID: 37844691
- DOI: 10.1016/j.jaad.2023.10.011
Sensitivity of personalized circulating tumor DNA assay in advanced cutaneous squamous cell carcinoma
Keywords: circulating tumor DNA; clinical research; cutaneous oncology; medical dermatology; squamous cell carcinoma; tumor biomarkers.
Conflict of interest statement
Conflicts of interest Dr Silk reports receiving Grants/Research Support (to the Institution) from Biohaven Pharmaceuticals, Replimune, Morphogenesis, Shattuck Laboratories, advisory board fees from InStil Bio, Signatera, and Merck, and royalties from UpToDate. The other authors have no conflict of interest to declare.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical